Hanmi Science (008930) - Total Assets

Latest as of December 2025: ₩1.49 Trillion KRW ≈ $1.01 Billion USD

Based on the latest financial reports, Hanmi Science (008930) holds total assets worth ₩1.49 Trillion KRW (≈ $1.01 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 008930 net assets for net asset value and shareholders' equity analysis.

Hanmi Science - Total Assets Trend (2000–2025)

This chart illustrates how Hanmi Science's total assets have evolved over time, based on quarterly financial data.

Hanmi Science - Asset Composition Analysis

Current Asset Composition (December 2025)

Hanmi Science's total assets of ₩1.49 Trillion consist of 28.6% current assets and 71.4% non-current assets.

Asset Category	Amount (KRW)	% of Total Assets
Cash & Equivalents	₩0.00	8.6%
Accounts Receivable	₩104.39 Billion	7.0%
Inventory	₩122.54 Billion	8.2%
Property, Plant & Equipment	₩0.00	0.0%
Intangible Assets	₩15.75 Billion	1.1%
Goodwill	₩0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Hanmi Science's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 008930 stock market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Hanmi Science's current assets represent 28.6% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, down from 9.0% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is inventory at 8.2% of total assets.

Hanmi Science Competitors by Total Assets

Key competitors of Hanmi Science based on total assets are shown below.

Company	Country	Total Assets
Sigma Healthcare Ltd AU:SIG	Australia	AU$8.74 Billion
Ebos Group Ltd AU:EBO	Australia	AU$7.84 Billion
Paragon Care Ltd AU:PGC	Australia	AU$1.31 Billion
Mayne Pharma Group Ltd AU:MYX	Australia	AU$1.01 Billion
Cyclopharm Ltd AU:CYC	Australia	AU$55.91 Million
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Brazil	R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	China	CN¥233.15 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHG:600332	China	CN¥83.17 Billion

Hanmi Science - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.88	0.70	0.94
Quick Ratio	0.63	0.47	0.47
Cash Ratio	0.00	0.00	0.00
Working Capital	₩-57.78 Billion	₩-140.86 Billion	₩-13.30 Billion

Hanmi Science - Advanced Valuation Insights

This section examines the relationship between Hanmi Science's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.71
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	10.4%
Total Assets	₩1.49 Trillion
Market Capitalization	$1.73 Billion USD

Valuation Analysis

Below Book Valuation: The market values Hanmi Science's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Hanmi Science's assets grew by 10.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Hanmi Science (2000–2025)

The table below shows the annual total assets of Hanmi Science from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	₩1.49 Trillion ≈ $1.01 Billion	+10.38%
2024-12-31	₩1.35 Trillion ≈ $914.25 Million	+10.02%
2023-12-31	₩1.23 Trillion ≈ $830.96 Million	+10.50%
2022-12-31	₩1.11 Trillion ≈ $752.02 Million	+16.82%
2021-12-31	₩949.89 Billion ≈ $643.73 Million	+2.89%
2020-12-31	₩923.22 Billion ≈ $625.65 Million	+1.36%
2019-12-31	₩910.83 Billion ≈ $617.26 Million	-0.62%
2018-12-31	₩916.55 Billion ≈ $621.13 Million	-2.37%
2017-12-31	₩938.78 Billion ≈ $636.20 Million	-3.14%
2016-12-31	₩969.25 Billion ≈ $656.85 Million	+3.99%
2015-12-31	₩932.02 Billion ≈ $631.62 Million	+25.48%
2014-12-31	₩742.80 Billion ≈ $503.38 Million	+28.11%
2013-12-31	₩579.82 Billion ≈ $392.94 Million	+19.45%
2012-12-31	₩485.39 Billion ≈ $328.94 Million	+19.51%
2011-12-31	₩406.16 Billion ≈ $275.25 Million	-60.56%
2010-12-31	₩1.03 Trillion ≈ $697.86 Million	+15.00%
2009-12-31	₩895.44 Billion ≈ $606.83 Million	+6.80%
2008-12-31	₩838.43 Billion ≈ $568.19 Million	+21.48%
2007-12-31	₩690.20 Billion ≈ $467.74 Million	+31.33%
2006-12-31	₩525.55 Billion ≈ $356.16 Million	+28.52%
2005-12-31	₩408.94 Billion ≈ $277.13 Million	+12.08%
2004-12-31	₩364.87 Billion ≈ $247.27 Million	+11.30%
2003-12-31	₩327.82 Billion ≈ $222.16 Million	+7.30%
2002-12-31	₩305.50 Billion ≈ $207.04 Million	+3.27%
2001-12-31	₩295.82 Billion ≈ $200.48 Million	+19.68%
2000-12-31	₩247.17 Billion ≈ $167.50 Million	--

About Hanmi Science

KO:008930 Korea Medical Distribution

Market Cap

$1.73 Billion

₩2.55 Trillion KRW

Market Cap Rank

#6806 Global

#187 in Korea

Share Price

₩37700.00

Change (1 day)

-0.79%

52-Week Range

₩28500.00 - ₩51900.00

All Time High

₩138933.39